Improving Processes of Cancer Care Delivery at a Comprehensive Cancer Center
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Discussion, Electronic Health Record Review, Questionnaire Administration.
- Who it may be relevant to
- Registry conditions: Metastatic Malignant Solid Neoplasm. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Mapping the Processes of Cancer Care Delivery at a Comprehensive Cancer Center
Overview
This study examines how cancer care is delivered in oncology and supportive care clinics. Collecting patient feedback may help doctors better understand the processes of cancer care in oncology and supportive care clinics.
Detailed description
PRIMARY OBJECTIVES:
I. To compare the total amount of follow-up clinic time spent on discussing supportive/palliative care issues between primary palliative care provided by the oncology team and specialist palliative care.
SECONDARY OBJECTIVES:
I. To compare between the specialist palliative care team and the oncology team the following aspects of supportive/palliative care delivery: Ia. The number of supportive/palliative care needs the patient reported before the clinic visit (SPARC).
Ib. The number of supportive/palliative care needs the patient wanted to discuss with the clinical team before the clinic visit (SPARC).
Ic. The number of supportive/palliative care needs that were actually raised by the patient during the clinic visit (audiotape).
Id. The number of supportive/palliative care needs that were actually discussed by the clinical team during clinic visit (audiotape).
Ie. The number of supportive/palliative care needs that were documented in progress note by the clinical team after each visit (electronic health record).
If. The number of supportive/palliative care needs that the patient reported had been adequate addressed after the clinic visit (SPARC).
II. To compare the amount of clinic time (both absolute and proportion) spent on discussing supportive/palliative care issues by individual disciplines (e.g. medical doctor, registered nurse, counselor, pharmacist, psychologist, social worker, and priest) between the specialist palliative care team and the oncology team.
III. To examine the nature of topics discussed by the specialist palliative care team and the oncology team and compare the amount of clinic time (both absolute and proportion) spent on each supportive/palliative care issue.
IV. To compare the number of empathic statements between the specialist palliative care team and the oncology team.
V. To compare the processes of supportive/palliative care delivery between patients seeing the oncology team without specialist palliative care (Cohort A) and patients seeing the oncology team when specialist palliative care team is involved (Cohort B).
OUTLINE:
Patients complete questionnaires over 15-20 minutes and undergo audio recording of clinic conversations between the oncology team or the specialist palliative care team. Patients' medical records are also reviewed.
Interventions
- Procedure Discussion
Undergo audio recording of clinic conversations - Other Electronic Health Record Review
Review of medical records - Other Questionnaire Administration
Complete questionnaires
Primary outcome measures
- Minutes spent in discussion [Time frame: through study completion, an average of 1 year]
Eligibility criteria
Inclusion criteria
- Within 6 months of diagnosis of metastatic (or stage IV) solid malignancies
- Age 18 or greater
- English speaking
- Follow-up clinic visit (Supportive Care and Medical Oncology Outpatient Clinics at MD Anderson Cancer Center)
- Medical oncologist listed as the attending physician
- COHORT A (Oncology team only cohort): Patients should not have been referred to palliative care services at MD Anderson Cancer Center
- COHORT B (Oncology team and specialist palliative care cohort): Patients should have an upcoming specialist palliative care follow-up visit within 1 week of a medical oncology visit
Exclusion criteria
- Delirium (Memorial Delirium Assessment Scale \[MDAS\] >= 13/30)
- Significant hearing impairment requiring multiple repetitions during the screening process (that may prolong clinic time)
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
United States · 1 center
- M D Anderson Cancer Center — Houston
Identifiers
NCT: NCT05095948 · 2020-0246 · NCI-2021-10266 · 2020-0246